The two CD95 apoptosis signaling pathways may be a way of cells to respond to different amounts and/or forms of CD95 ligand produced in different tissues
- 27 July 2000
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 7 (8) , 756-758
- https://doi.org/10.1038/sj.cdd.4400707
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- TRAIL receptor-2 signals apoptosis through FADD and caspase-8Nature Cell Biology, 2000
- Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xLProceedings of the National Academy of Sciences, 1999
- Letter to the EditorCell Death & Differentiation, 1999
- Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II CellsJournal of Biological Chemistry, 1999
- Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas DeathJournal of Biological Chemistry, 1999
- Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian DevelopmentCell, 1998
- Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain DevelopmentCell, 1998
- Two CD95 (APO-1/Fas) signaling pathwaysThe EMBO Journal, 1998
- Resistance of cultured peripheral T cells towards activation‐induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death‐inducing signaling complexEuropean Journal of Immunology, 1997
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995